A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.
about
Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptorA tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activityLymphotoxin and TNF: how it all began-a tribute to the travelersCharacterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor.Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor.Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.Levels of inhibitors of tumor necrosis factor alpha and interleukin 1beta in urine and sera of patients with urosepsis.A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor.Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB.Tumour necrosis factor and anti-tumour necrosis factor approach to inflammatory demyelinating diseases of the central nervous system.The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.How are the regulators regulated? The search for mechanisms that impose specificity on induction of cell death and NF-kappaB activation by members of the TNF/NGF receptor family.Double-stranded RNA induces shedding of the 34-kDa soluble TNFR1 from human airway epithelial cells via TLR3-TRIF-RIP1-dependent signaling: roles for dual oxidase 2- and caspase-dependent pathways.Metabolism in patients with small cell lung carcinoma compared with patients with non-small cell lung carcinoma and healthy controls.Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation.Identification of soluble forms of the fibroblast growth factor receptor in bloodSelective enhancement of the tumour necrotic activity of TNF alpha with monoclonal antibodyRelease of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors.Progressive growth of human papillomavirus type 16-transformed keratinocytes is associated with an increased release of soluble tumour necrosis factor (TNF) receptor.Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activationThe epitopes for natural polyreactive antibodies are rich in proline.Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors.Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis.cAMP-dependent protein kinase A (PKA) signaling induces TNFR1 exosome-like vesicle release via anchoring of PKA regulatory subunit RIIbeta to BIG2.Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivoShedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.Persistent p55TNFR expression impairs T cell responses during chronic tuberculosis and promotes reactivationPolymorphisms in the tumor necrosis factor receptor genes affect the expression levels of membrane-bound type I and type II receptors.Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures.IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells.Involvement of tumor necrosis factor alpha in intracellular multiplication of Legionella pneumophila in human monocytes.On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparinCharacterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes.Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.Membrane protein secretasesDual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity.Soluble interleukin-6 receptor is released from receptor-bearing cell lines in vitro.
P2860
Q24304040-44F9A45F-DB42-450E-8BCE-5AE3E47117D0Q24675629-76FE4E45-58AC-4D93-89E4-7A41E36FFC64Q26865649-559579AD-C146-4E25-8EDA-B3ACA037BA2BQ33673534-46E43687-D749-4A1C-85FB-227661B5B39AQ33739657-59ECF717-BD74-4913-96F9-8BD43D087D63Q33741548-A451506C-BDFF-4F18-95E6-51005DDA73E5Q33757212-3B0319E3-7E99-4818-893F-E3C91E8AB39FQ33864621-83136C39-8DE9-430E-814E-495633ED4FE3Q33937497-AA246DCB-89E2-4421-8A85-BA11F50FCCECQ34071248-433CF5BC-171F-455F-8F94-DCE7F523328CQ34071322-6B825001-BE09-4856-AEDA-40500A2E4645Q34607576-E96464DD-6B5E-4FF7-BD70-73C44AE1B2C4Q34731204-71FA86CE-262F-41A5-BC10-74F69905CA35Q34788072-F19343A9-E3EF-4E11-8B22-D4DB493EA127Q35563502-0FF7F9F2-0711-4CE5-AAA2-46C96D4AA3CAQ35714438-FFF1D3DB-63BC-450C-AAA0-9772B289E508Q35767983-217CDC79-0A6B-45D0-8941-604A57431DAFQ35994055-1C0F5C50-A065-47B8-82E1-530A183A920CQ36017850-42126BA0-E83E-45FC-A069-EC9F0D1B35A7Q36135454-5459566B-960D-47BC-BEBD-DD54ACED62ACQ36168851-53063015-77B6-401A-BD47-3AAFA3947E8DQ36184425-C5C0D975-EC63-486F-852D-ED81B35DA309Q36230900-440918B6-FFBF-49A7-99EA-9F4BF3C94542Q36361402-E844BB8E-A077-49F1-B6BF-9471CB5638D6Q36689099-A3D54D15-4044-444C-8EA2-C8F06448077CQ36869457-A4113F09-8179-4A79-8981-AEDB1F95F145Q37031936-28CF382C-BB30-48A4-9FB2-02339FD6D6FAQ37378024-DFB4FE05-5351-46AB-8C48-E54579EF014FQ37518463-79389405-A41D-4829-9E3E-183286C85AF8Q37696010-856B19F7-A3B5-4656-AC32-0619D6F24B0FQ39766387-45864FBD-A77C-4E78-B3C1-DDCA69DD49B2Q39881543-81FA356F-CB07-41E2-A1AE-477C9524BF0AQ40269694-F7CFEB9C-2D7D-4C47-B8BA-C6B474ED0BCFQ40343302-7740EEB3-133A-410F-8AC8-358DB354ED9AQ40348334-81AFDC27-7CA4-4FEE-815A-86D0AA54369AQ40614560-2DD352C2-0DCB-457E-8A38-201E05DFFE20Q41207115-4B73734C-06A3-4103-A20C-3D2C89EABBD2Q41341215-C7441225-7E74-424C-9F3D-52DED4A00E75Q41453450-F1269CC5-CA11-4877-8838-10700E1FD97BQ41632279-E0A879DC-F8B1-4C09-9C18-1A6625B8719F
P2860
A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
A tumor necrosis factor-bindin ...... umor necrosis factor toxicity.
@en
A tumor necrosis factor-bindin ...... umor necrosis factor toxicity.
@nl
type
label
A tumor necrosis factor-bindin ...... umor necrosis factor toxicity.
@en
A tumor necrosis factor-bindin ...... umor necrosis factor toxicity.
@nl
prefLabel
A tumor necrosis factor-bindin ...... umor necrosis factor toxicity.
@en
A tumor necrosis factor-bindin ...... umor necrosis factor toxicity.
@nl
P2093
P1476
A tumor necrosis factor-bindin ...... tumor necrosis factor toxicity
@en
P2093
P304
11974-11980
P407
P577
1989-07-01T00:00:00Z